Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Indeterminate results of quantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2008; 32: Suppl. 52, 2525

Member's Comments

No comment yet.

Related content which might interest you: Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Source: Eur Respir J 2009; 33: 812-815 Year: 2009 Indeterminate IGRA results in routine practice Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Source: Eur Respir J 2007; 30: 945-950 Year: 2007 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 Practical use of quantiferon test in Norway‘s largest TB-clinic Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Usefulness of a daignostic method of tuberculosis infection, QuantiFERON TB-2G, in a contact investigation of medical staffs Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017 Year: 2017 Clinical evaluation of QuantiFERON TB-2G test for patients with active tuberculosis disease stratified by age groups Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Pulmonary function tests in clinical practice Source: Annual Congress 2013 –PG17 Diagnostic tests for paediatric pulmonologists Year: 2013 Diagnostic efficiency Diaskintest and Quantiferon test in comparison with the Mantoux test for active tuberculosis in children in Belarus Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 The diagnostic efficiency of TB quantiferon gold test in tuberculosis (preeliminary reports) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Indication, interpretation and clinical utility of bronchoprovocation testing Source: Annual Congress 2012 - New ATS/ERS recommendations for bronchoprovocation challenge testing Year: 2012 Improved diagnostic evaluation of suspected tuberculosis in routine practice Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Is utility of D-Dimer test undermined because of overuse in routine clinical practise? Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Serial QuantiFERON TB-2G testing for 4 years of health care workers in a city hospital Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013